NSCLC tumor samples; corresponding non-tumor samples; xenograft tumors
16 HBE; H1299; A549; HCC827; H460
cell line-derived xenograft
proliferation (inhibits); apoptosis (promotes); migration (inhibits); invasion (inhibits); stemness (inhibits); ERK (inhibits); ceRNA regulation (promotes)
RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Transfection; Colony Formation Assay; EdU Staining; Annexin V/PI Flow Cytometry; Transwell Assay; In Vivo Animal Model; IHC (Immunohistochemistry); Western Blot; Bioinformatics Analysis; Microarray
-
In NSCLC, circ_0006677 is down-regulated and acts as a tumor suppressor. It sponges miR-1245a to increase SATB2 expression and thereby inhibits malignant phenotypes (proliferation, migration, invasion, stemness) while promoting apoptosis, partly via inhibiting MEK/ERK signaling.
0.8254
Hsa_circ_0006677 regulates special AT-rich binding protein-2-mediated tumor-suppressive effect via functioning as a miR-1245a sponge in non-small cell lung cancer.
combined biological and clinical study